You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-LYVE1 antibody - Lymphatic Vessel Marker (ab14917)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-LYVE1 antibody - Lymphatic Vessel Marker
See all LYVE1 products (8) ...

Description

Rabbit polyclonal to LYVE1 - Lymphatic Vessel Marker

Tested applications

ELISA, WB, IHC-Fr, IHC-Pmore details

Cross reactivity

Reacts with

Mouse

Immunogen

Recombinant mouse soluble LYVE1, consisting of amino acids 24 to 228 fused to a C-terminal His-tag (6xHis), produced in insect cells.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: None
Constituents: PBS, pH 7.4

Concentration

Concentration information loading...

Purity

Protein A purified

Purification notes

Protein-A Chromatography (+his tag depleted).

Clonality

Polyclonal

Isotype

IgG

  • Immunohistochemistry (Paraffin-embedded sections) - LYVE1 antibody - Lymphatic Vessel Marker (ab14917)Immunohistochemistry (Paraffin-embedded sections) - LYVE1 antibody - Lymphatic Vessel Marker (ab14917) image (enlarge)

  • Immunohistochemistry (Paraffin-embedded sections) - LYVE1 antibody - Lymphatic Vessel Marker (ab14917)Immunohistochemistry (Paraffin-embedded sections) - LYVE1 antibody - Lymphatic Vessel Marker (ab14917) image (enlarge)

  • Immunohistochemistry (Frozen sections) - LYVE1 antibody - Lymphatic Vessel Marker (ab14917)Immunohistochemistry (Frozen sections) - LYVE1 antibody - Lymphatic Vessel Marker (ab14917) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab14917 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

ELISA: Use at a concentration of 1 - 15 µg/ml.
IHC-P: Use at an assay dependent concentration.
IHC-Fr: Use at a concentration of 1 - 5 µg/ml.
WB: Use at a concentration of 1 - 2 µg/ml. Predicted molecular weight: 35 kDa.

Not tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Ligand-specific transporter trafficking between intracellular organelles (TGN) and the plasma membrane. Plays a role in autocrine regulation of cell growth mediated by growth regulators containing cell surface retention sequence binding (CRS). May act as an hyaluronan (HA) transporter, either mediating its uptake for catabolism within lymphatic endothelial cells themselves, or its transport into the lumen of afferent lymphatic vessels for subsequent re-uptake and degradation in lymph nodes.

Tissue specificity

Mainly expressed in endothelial cells lining lymphatic vessels.

Sequence similarities

Contains 1 Link domain.

Post-translational
modifications

O-glycosylated.

Cellular localization

Membrane. Localized to the plasma membrane and in vesicles near extranuclear membranes which may represent trans-Golgi network (TGN) and endosomes/prelysosomeal compartments. Undergoes ligand-dependent internalization and recycling at the cell surface.

Target information above from: UniProt accessionQ9Y5Y7 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Cell surface retention sequence-binding protein 1 antibody
  • CRSBP 1 antibody
  • CRSBP-1 antibody
  • CRSBP1 antibody
  • extracellular link domain containing 1 antibody
  • extracellular link domain-containing 1 antibody
  • Extracellular link domain-containing protein 1 antibody
  • HAR antibody
  • hyaluronic acid receptor antibody
  • Lymphatic endothelium specific hyaluronan receptor antibody
  • lymphatic vessel endothelial hyaluronan receptor 1 antibody
  • Lymphatic vessel endothelial hyaluronic acid receptor 1 antibody
  • LYVE 1 antibody
  • LYVE-1 antibody
  • LYVE1 antibody
  • LYVE1_HUMAN antibody
  • XLKD1 antibody
see all

Anti-LYVE1 antibody - Lymphatic Vessel Marker images:

  Immunohistochemistry (Paraffin-embedded sections) - LYVE1 antibody - Lymphatic Vessel Marker (ab14917)

Immunohistochemistry (Paraffin-embedded sections) - LYVE1 antibody - Lymphatic Vessel Marker (ab14917)

ab14917 at a 1/100 dilution staining LYVE1 from mouse tuberculosis infected lung by immunohistochemistry (paraffin-embedded sections). The antibody was incubated with the tissue for 30 minutes and then detected with an HRP conjugated goat anti-rabbit antibody.

This image is courtesy of an Abreview submitted by Elizabeth Chlipala on 18 November 2005.

See Abreview

  Immunohistochemistry (Paraffin-embedded sections) - LYVE1 antibody - Lymphatic Vessel Marker (ab14917)

Immunohistochemistry (Paraffin-embedded sections) - LYVE1 antibody - Lymphatic Vessel Marker (ab14917)

ab14917 at 1/2000 dilution staining Ha-Ras transgenic mouse bladder (cancer) by Immunohistochemistry (Formalin-fixed paraffin-embedded sections). The tissue was formaldehyde fixed and blocked with serum prior to incubation with the primary antibody for 12 hours. A biotinylated polyclonal antibody was used as the secondary.

This image is courtesy of an anonymous Abreview

See Abreview

  Immunohistochemistry (Frozen sections) - LYVE1 antibody - Lymphatic Vessel Marker (ab14917)

Immunohistochemistry (Frozen sections) - LYVE1 antibody - Lymphatic Vessel Marker (ab14917)

 ab14917 at 1/100 staining mouse tissue sections (E17.5 lymphatic vessels by inferior vena cava) by IHC-Fr. The tissue was acetone fixed and incubated with the antibody for 2 hours in 1% BSA in PBS. An Alexa Fluor ® 488 conjugated donkey anti-rabbit IgG antibody was used as the secondary.

This image is courtesy of an Abreview submitted by Miss Lise Sorensen

See Abreview

References for Anti-LYVE1 antibody - Lymphatic Vessel Marker (ab14917)

This product has been referenced in:

  • Boimel PJ  et al. fContribution of CXCL12 secretion to invasion of breast cancer cells. Breast Cancer Res 14:R23 (2012). IHC-P.Read more (PubMed: 22314082) »
  • Martínez-Corral I  et al. In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis. Proc Natl Acad Sci U S A 109:6223-8 (2012). IHC (PFA fixed); Mouse.Read more (PubMed: 22474390) »

See all 31 publications for this product

Publishing research using ab14917? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"